跳至主要内容
临床试验/JPRN-UMIN000008576
JPRN-UMIN000008576已完成未知

To investigate the efficacy and safety of lenalidomide and dexamethasone for elderly or frail patients with relapsed/refractory multiple myeloma - Iwate Study MM2012

Iwate Myeloma treatment Study Group0 个研究点目标入组 53 人开始时间: 2012年8月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
53

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. History of hypersensitivity to lenalidomide. 2. Non-secretory MM and plasma cell leukemia. 3. Patients HIV-positive, HBsAg-positive, HCV-positive. 4. Severe hepatic dysfunction, severe renal failure, severe cardiac dysfunction, severe pulmonary dysfunction, uncontrolled hypertension, and uncontrolled infection. 5. Patients with psychiatric disorders. 6. Pregnant women, pre-menopausal women and lactating women. 7. Patients with a history of active malignancy. 8. Those who are considered as inappropriate register by attending physicians.

研究者

发起方
Iwate Myeloma treatment Study Group

相似试验

进行中(未招募)
不适用
Evaluation of efficacy and safety of Lenalidomide (Revlimid) in patients with POEMS Syndrome - ONC-2008-002POEMS SYNDROMEMedDRA version: 9.1Level: SOCClassification code 10029205
EUCTR2008-003202-33-ITISTITUTO CLINICO HUMANITAS
招募中
2 期
A feasibility study to evaluate the utility of a drug (lenalidomide) for preventing recurence in patients with Primary central nervous system lymphoma.This study will use a drug called lenalidomide for 2 years after completion of standard treatment with aim of preventing recurences.
CTRI/2019/04/018546Tata Memorial Center
进行中(未招募)
1 期
Phase II study evaluating the efficacy of Lenalidomide in association with Rituximab in refractory or relapse of primary central nervous system lymphomaPrimary central nervous system or Intra ocular lymphoma in relapse or refractory to previous treatmentMedDRA version: 14.1Level: LLTClassification code 10051811Term: Cerebral lymphomaSystem Organ Class: 100000004864
EUCTR2012-003786-17-FRINSTITUT CURIE45
已完成
4 期
The study to evaluate the efficacy and safety of linear high intensity focus ultrasound for enlarged pores in Thailand, Pilot studyHealthy human volunteersHigh intensity focused ultrasoundFaceSkin
TCTR20220701006Dermatologic Surgery, Dermatology department, Siriraj hospital, Thailand30
已完成
4 期
The study to evaluate the efficacy and safety of linear high intensity focus ultrasound for lower face sagging in Thailand, A pilot studyHealthy human volunteersHigh intensity focused ultrasoundFaceSkin
TCTR20220629011Dermatologic Surgery, Dermatology department, Siriraj hospital, Thailand30